SUNNYVALE, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- Amarantus BioSciences Inc. (OTCBB:AMBS), a California-based biotechnology company focused on the development of a therapeutic protein known as MANF, announced today that TomorrowsBlueChips.com has profiled it in a 9-page research report that can be found directly on the web site under its Research section: http://tomorrowsbluechips.com/research/
